Invention Grant
- Patent Title: Method of binding a CSE1L tumor marker in a tumor of an animal
-
Application No.: US15257669Application Date: 2016-09-06
-
Publication No.: US10172963B2Publication Date: 2019-01-08
- Inventor: Ming-Chung Jiang
- Applicant: Ming-Chung Jiang
- Applicant Address: US CA Encinitas US CA Encinitas
- Assignee: Matthew A. Pequignot,Michael G. Sullivan
- Current Assignee: Matthew A. Pequignot,Michael G. Sullivan
- Current Assignee Address: US CA Encinitas US CA Encinitas
- Agency: Pequignot + Myers LLC
- Priority: WOPCT/CN2011/078559 20110818
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61K39/395 ; C07K16/28 ; G01N33/68 ; C07K16/18 ; C07K16/30 ; G01N33/574
Abstract:
Microvesicles play essential roles in disease progression. The present invention provides a microvesicle membrane protein and application thereof. Disclosed is a method comprising phosphorylated CSE1L (cellular apoptosis susceptibility protein)- or CSE1L-binding agents for microvesicle isolation, analysis, or binding for disease diagnosis.
Public/Granted literature
- US20170080110A1 METHOD OF BINDING A CSE1L TUMOR MARKER IN A TUMOR OF AN ANIMAL Public/Granted day:2017-03-23
Information query
